Vertex Pharmaceuticals Inc. buy Morgan Stanley
Start price
10.04.26
/
50%
€371.55
Target price
10.04.27
€523.50
Performance (%)
20.56%
Price
13.08.26
€447.95
Summary
This prediction is currently active. The prediction currently has a performance of 20.56%. This prediction currently runs until 10.04.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 6.604% | 6.604% |
| iShares Core DAX® | 0.881% | 5.632% |
| iShares Nasdaq 100 | 2.390% | 1.571% |
| iShares Nikkei 225® | 4.269% | 2.521% |
| iShares S&P 500 | 1.171% | 2.545% |
Comments by Morgan_Stanley for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (VRTX) was given a new $612.00 price target by Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€357.25
05.05.26
05.05.26
€527.05
05.05.27
05.05.27
25.39%
13.08.26
13.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€429.85
10.03.26
10.03.26
€512.68
10.03.27
10.03.27
4.21%
13.08.26
13.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€420.00
13.02.26
13.02.26
-
13.02.27
13.02.27
6.65%
13.08.26
13.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€375.90
03.12.25
03.12.25
€443.40
03.12.26
03.12.26
19.17%
13.08.26
13.08.26